CASP3 and cancer: DG acts against cancers via the following pathways and mechanisms: (1) the STAT pathway, (2) activation of caspase-3 and p53, (3) activation of the TRAIL death receptor DR5 and (4) the Wnt-β-catenin pathway (147).